BioStem Technologies, (id:11477 BSEM)
13.92 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 9:49:42 PM)
Exchange closed, opens in 11 hours 40 minutes
About BioStem Technologies,
Market Capitalization 227.21M
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
| Headquarters (address) |
2836 Center Port Circle Pompano Beach 33064 FL United States |
| Phone | 954 380 8342 |
| Website | https://www.biostemtechnologies.com |
| Employees | 0 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | BSEM |
| Exchange | OTC Markets U.S. |
| Currency | USD |
| 52 week range | 2.96 - 28.26 |
| Market Capitalization | 227.21M |
| P/E trailing | -22.45 |
| P/E forward | 6.69 |
| Price/Sale | 33.05 |
| Price/Book | -53.28 |
| Beta | 1.78 |
| EPS | -0.730 |
| EPS United States (ID:6, base:3402) | 24.23 |